glp 1 hormone therapy Can support better weight loss outcomes with GLP-1 medications? Emerging research suggests it might. A 2024 study found that postmenopausal women who used hormone replacement therapy (HRT) alongside a GLP-1 GLP-1 and Hormone Therapy for

GLP-1 RAs mimic the action of a natural hormone to help regulate blood glucose

Agitation and restlessness: ALCAR may cause agitation in some users

Your clinician will weigh risks and benefits and may suggest a different plan if GLP-1s arent a fit

Whilst Saxenda is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for obesity treatment, changes in libido are not listed as recognised side effects in the UK Summary of Product Characteristics

These changes and alterations in limbic regions like ACC and amygdala are more pronounced in non-treated populations and seem to diminish over time from child to adulthood

10.1016/S2213-8587(13)70021-4 16